{"log_id": 1074471068610677517, "direction": 0, "words_result_num": 47, "words_result": [{"words": "核准期:206年08月17日", "probability": {"variance": 0.002176, "average": 0.971506, "min": 0.872464}}, {"words": "修改日期:2009年06月12日", "probability": {"variance": 0.001639, "average": 0.97878, "min": 0.856972}}, {"words": "修改日期:2010年10月团", "probability": {"variance": 0.018008, "average": 0.914409, "min": 0.541218}}, {"words": "亚叶酸钙注射液说明书", "probability": {"variance": 0, "average": 0.999564, "min": 0.99805}}, {"words": "请仔纽阅读说明书并在医师指导下使用", "probability": {"variance": 0.012101, "average": 0.972105, "min": 0.53209}}, {"words": "【药名称", "probability": {"variance": 0.045262, "average": 0.855617, "min": 0.489542}}, {"words": "通用名称:亚叶酸钙注射液", "probability": {"variance": 0.002776, "average": 0.970025, "min": 0.800348}}, {"words": "商名称;同", "probability": {"variance": 0.061432, "average": 0.802348, "min": 0.362645}}, {"words": "英文名称: Cale", "probability": {"variance": 0.000854, "average": 0.985346, "min": 0.920072}}, {"words": "汉谦拼:Y", "probability": {"variance": 0.066768, "average": 0.803793, "min": 0.397969}}, {"words": "Zh", "probability": {"variance": 0.004303, "average": 0.875922, "min": 0.810323}}, {"words": "成份】", "probability": {"variance": 0.008497, "average": 0.891386, "min": 0.773916}}, {"words": "本主要成份为:亚建酸钙。其化学名称为:N-(2-氨基-5-甲航基", "probability": {"variance": 0.025101, "average": 0.909178, "min": 0.417681}}, {"words": "氢-4氧代6一蝶啶基)甲基]氨基苯", "probability": {"variance": 0.011181, "average": 0.92771, "min": 0.611701}}, {"words": "甲酰基-L谷氨酸钙盐五水合物", "probability": {"variance": 0.012174, "average": 0.93624, "min": 0.660254}}, {"words": "其结构式为", "probability": {"variance": 0.000508, "average": 0.987191, "min": 0.942194}}, {"words": "5", "probability": {"variance": 0, "average": 0.86109, "min": 0.86109}}, {"words": " CHO", "probability": {"variance": 0, "average": 0.941576, "min": 0.941576}}, {"words": "分子式:C20H21CaN2O25H2O", "probability": {"variance": 0.022735, "average": 0.918316, "min": 0.550797}}, {"words": "分子:601", "probability": {"variance": 0.001479, "average": 0.979236, "min": 0.89342}}, {"words": "本铺料为:氯化钠,硫硫酸钠:1.2-丙二醇", "probability": {"variance": 0.02352, "average": 0.910473, "min": 0.426604}}, {"words": "【性状", "probability": {"variance": 0.000118, "average": 0.98491, "min": 0.973897}}, {"words": "本品为淡黄色至黄色的澄明液体", "probability": {"variance": 0.002423, "average": 0.980308, "min": 0.804179}}, {"words": "【适应】", "probability": {"variance": 0.061862, "average": 0.86781, "min": 0.370844}}, {"words": "尿嘧啶合用,可提高氟尿嘧啶的疗效,临床上常用于结直肠癌与胃癌的治疗", "probability": {"variance": 0.00363, "average": 0.967711, "min": 0.746814}}, {"words": "作叶酸拮抗剂(如甲氨蝶呤、乙胺嘧啶或甲氧啶等)的解毒剂。本临床常用于预防甲氨蝶呤过量等大剂治疗", "probability": {"variance": 0.008022, "average": 0.947555, "min": 0.651812}}, {"words": "后所引起的严重毒性作用", "probability": {"variance": 0.001146, "average": 0.981077, "min": 0.884063}}, {"words": "当口服叶酸疗效不佳时,也用于口炎性腹泻、养不良、妊嫩期或婴儿期引起的巨幼细胞性贫血:但对维生素B2缺", "probability": {"variance": 0.024648, "average": 0.912303, "min": 0.414128}}, {"words": "乏性贫血井不适用", "probability": {"variance": 0.005394, "average": 0.964304, "min": 0.774225}}, {"words": "规格】", "probability": {"variance": 8.5e-05, "average": 0.988814, "min": 0.976077}}, {"words": "1ml:0.1g《按C20H2N2O计)(2", "probability": {"variance": 0.022525, "average": 0.870542, "min": 0.50512}}, {"words": "(按C2H2NO请", "probability": {"variance": 0.028649, "average": 0.875756, "min": 0.617862}}, {"words": "【用法用】", "probability": {"variance": 6.3e-05, "average": 0.993594, "min": 0.980479}}, {"words": "1用于5Fu食用增效,每次20~500mg/m2,静滴,每日次,连用5天。可用生理盐水或葡萄糖注射液稀释配成输注", "probability": {"variance": 0.01721, "average": 0.931222, "min": 0.434661}}, {"words": "液,配制后的输注液p不得少于6.5。输注液须新鲜配制", "probability": {"variance": 0.009383, "average": 0.954703, "min": 0.540621}}, {"words": "2作为甲氨蝶呤的“解救”疗法,本品剂量最好根据血药浓度测定。一般采用的剂量为按体表面积", "probability": {"variance": 0.008689, "average": 0.965757, "min": 0.463045}}, {"words": "g/m2,肌注或静", "probability": {"variance": 0.002629, "average": 0.96794, "min": 0.83254}}, {"words": "注,每6小时1次,共用12次:作为乙胺嘧啶或甲氧苄啶等的解毒剂,每次剂量为肌注9", "probability": {"variance": 0.00242, "average": 0.983952, "min": 0.745592}}, {"words": "视中毒情况而定", "probability": {"variance": 0.029714, "average": 0.889641, "min": 0.479136}}, {"words": "【不良反应】", "probability": {"variance": 9e-06, "average": 0.997715, "min": 0.9912}}, {"words": "很少见,偶见皮疹、導麻疹或哮嚼等其他过敏反应", "probability": {"variance": 0.007003, "average": 0.958081, "min": 0.66886}}, {"words": "【禁忌】", "probability": {"variance": 3.1e-05, "average": 0.991743, "min": 0.985299}}, {"words": "恶性贫血或维生素B12缺乏所引起的幼细胞性贫", "probability": {"variance": 0.020969, "average": 0.941882, "min": 0.414845}}, {"words": "【注意事项】", "probability": {"variance": 8e-06, "average": 0.996965, "min": 0.992195}}, {"words": "当患者有下列情况者,本品应谦慎用于甲氨蝶呤的“解救”治疗:酸性(pH<7)、腹水、失水、肠道梗阻、胸腔", "probability": {"variance": 0.011511, "average": 0.954769, "min": 0.395463}}, {"words": "渗液或肾功能障碍。有上述情况时,甲氨蝶呤毒性较显著,且不易从体内排出;病况急需者,本品剂量要加大", "probability": {"variance": 0.01447, "average": 0.9501, "min": 0.457016}}, {"words": "2.接受大剂量甲氨蝶岭而用本“解救”者应进行下列各种实验监察", "probability": {"variance": 0.004732, "average": 0.973807, "min": 0.650995}}], "language": 3}